doi:10.1586/ern.12.15 Stojanovski S, Scratch SE, Dunkley BT, Schachar R, Wheeler AL
Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high costsoften exceeding $1,000 per monthput them out of reach for many Americans whose insurance does not cover these medications
The inclusion of benzyl alcohol inhibits bacterial growth within the vial after initial puncture, allowing for multiple withdrawals under appropriate sterile handling conditions
The dosing regimen often starts with a lower dose to allow the body to adjust, reducing the likelihood of side effects such as nausea
Patience, measured in weeks
During sample collection an assessment as to whether an individual was affected with konzo was conducted following the WHOs 3 main criteria for diagnosis including evidence of (1) a visible symmetric spastic abnormality of gait while walking or running, (2) a history of onset of less than 1 week followed by a nonprogressive course in a formerly healthy person, and (3) bilaterally exaggerated knee or ankle jerks without signs of disease of the spine
